AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JULY 11, 2017
REGISTRATION NO. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
HEAT BIOLOGICS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 26-2844103 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
801 Capitola Drive
Durham, NC 27713
(919) 240-7133
(Address, including ZIP code, and telephone number, including
area code, of registrant's principal executive office)
HEAT BIOLOGICS, INC. 2017 STOCK INCENTIVE PLAN
(Full title of the Plan)
Jeffrey Wolf
Heat Biologics, Inc.
801 Capitola Drive
Durham, NC 27713
(919) 240-7133
(Name, address and telephone number of agent of services)
WITH COPIES TO:
Leslie Marlow, Esq.
Gracin & Marlow, LLP
The Chrysler Building
405 Lexington Avenue, 26th Floor
New York, New York 10174
(212) 907-6457
(Name, address and telephone number)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:
Large accelerated filer ¨ | Accelerated filer ¨ |
Non-accelerated filer ¨ | Smaller reporting company þ |
| Emerging growth company þ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. þ
CALCULATION OF REGISTRATION FEE
TITLE OF SECURITIES BEING REGISTERED |
| AMOUNT TO BE REGISTERED (1)(2) |
|
| PROPOSED MAXIMUM OFFERING PRICE PER SHARE(3) |
| PROPOSED MAXIMUM AGGREGATE OFFERING PRICE(3) |
|
| AMOUNT OF REGISTRATION FEE(4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, par value $0.0002 per share, under the 2017 Stock Incentive Plan |
| 5,000,000 |
|
| $0.58 |
| $2,900,000 |
|
| $336.11 |
|
————————
(1) | The securities to be registered include options and rights to acquire the common stock, par value $0.0002 per share (the “Common Stock”), of Heat Biologics, Inc. |
|
|
(2) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction. |
|
|
(3) | Estimated pursuant to Rule 457(c) and 457(h) of the Securities Act solely for purposes of calculating the registration fee. The price for the shares of Common Stock is based upon the average of the high and low prices of the Common Stock on July 7, 2017, as reported by the NASDAQ Capital Market. |
|
|
(4) | Calculated under Section 6(b) of the Securities Act as .00011590 of the proposed aggregate offering price. |
EXPLANATORY NOTE
Heat Biologics, Inc. (the “Registrant” or the “Company”) hereby files this Registration Statement on Form S-8 relating to its common stock, par value $0.0002 per share (the “Common Stock”), which have been reserved for issuance and are issuable pursuant to the Company’s 2017 Stock Incentive Plan (hereinafter referred to as the “Plan”).
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information specified in Item 1 and Item 2 of Part I of this Registration Statement on Form S-8 is omitted from this filing in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”), and the introductory note to Part I of Form S-8. The documents containing the information specified in Part I will be delivered to the participants in the Plan as required by Rule 428. Such documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE
The Securities and Exchange Commission (the “SEC”) allows us to “incorporate by reference” the information we file with it which means that we can disclose important information to you by referring you to those documents instead of having to repeat the information in this prospectus. The information incorporated by reference is considered to be part of this prospectus, and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below and any future filings made with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), between the date of this prospectus and the termination of the offering:
|
|
· | Our Annual Report on Form 10-K for the year ended December 31, 2016 (File No. 001-35994) filed with the SEC on March 31, 2017; |
· | Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 (File No. 001-35994) filed with the SEC on May 11, 2017; |
· | Our Current Reports on Form 8-K (File No. 001-35994) filed with the SEC on January 4, 2017, February 3, 2017, March 8, 2017, March 13, 2017, March 16, 2017, March 21, 2017, March 24, 2017, April 7, 2017, May 3, 2017, May 31, 2017, June 30, 2017 and July 11, 2017; and |
· | The description of our common stock set forth in our registration statement on Form 8-A, filed with the SEC on July 8, 2013 (File No. 001-35994).
|
All reports and other documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act shall be deemed to be incorporated by reference in this Registration Statement and to be a part of this Registration Statement from the respective date of filing of each of those reports or documents until the filing of a post-effective amendment to this Registration Statement which indicates either that all securities offered by this Registration Statement have been sold or which deregisters all of the securities under this Registration Statement then remaining unsold.
Any statement contained in this Registration Statement or in a document incorporated or deemed to be incorporated by reference in this Registration Statement shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in this Registration Statement or in any other subsequently filed document which also is or is deemed to be incorporated by reference in this Registration Statement modifies or supersedes that statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
ITEM 4. DESCRIPTION OF SECURITIES
Not applicable.
ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL
Not applicable.
ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS
Section 145 of the Delaware General Corporation Law authorizes a court to award, or a corporation’s board of directors to grant, indemnity to directors and officers in terms sufficiently broad to permit such indemnification under certain circumstances for liabilities, including reimbursement for expenses incurred, arising under the Securities Act.
Our amended and restated certificate of incorporation provides for indemnification of our directors and executive officers to the maximum extent permitted by the Delaware General Corporation Law, and our amended and restated bylaws provide for indemnification of our directors and executive officers to the maximum extent permitted by the Delaware General Corporation Law.
As permitted by the Delaware General Corporation Law, the Registrant has entered into indemnity agreements with each of its directors that require the Registrant to indemnify such persons against any and all costs and expenses (including attorneys’, witness or other professional fees) actually and reasonably incurred by such persons in connection with any action, suit or proceeding (including derivative actions), whether actual or threatened, to which any such person may be made a party by reason of the fact that such person is or was a director or officer or is or was acting or serving as an officer, director, employee or agent of the Registrant or any of its affiliated enterprises, provided that such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the Registrant’s best interests and, with respect to any criminal proceeding, had no reasonable cause to believe his or her conduct was unlawful. The indemnification agreements also set forth certain procedures that will apply in the event of a claim for indemnification thereunder.
ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED
Not applicable.
ITEM 8. EXHIBITS
Exhibit No. |
| Description of Document |
|
|
|
3.1 |
| Third Amended and Restated Certificate of Incorporation (1) |
3.2 |
| Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation (2) |
3.2 |
| Amended and Restated Bylaws (3) |
| Heat Biologics, Inc. 2017 Stock Incentive Plan (4) | |
| Opinion of Gracin & Marlow, LLP regarding Legality of Shares (4) | |
| Consent of BDO USA, LLP, Independent Registered Public Accounting Firm (4) | |
| Consent of Gracin & Marlow, LLP (contained in Exhibit 5.1) (4) | |
| Consent of BDO USA, LLP, Independent Auditor (4) | |
| Power of Attorney (included as part of the signature page to this Registration Statement and incorporated herein by reference) (4) |
————————
(1)
Incorporated by reference to the Registrant’s Form S-1 filed with the Securities and Exchange Commission on May 6, 2013.
(2)
Incorporated by reference to the Registrant’s Form S-1 filed with the Securities and Exchange Commission on May 30, 2013.
(3)
Incorporated by reference to the Registrant’s Form 8-K filed with the Securities and Exchange Commission on January 15, 2016.
(4)
Filed herewith.
ITEM 9. UNDERTAKINGS
The undersigned Registrant hereby undertakes:
1. To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
i. To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended;
ii. To reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement;
iii. To include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in the registration statement; provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in this Registration Statement.
2. That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
3. To remove from registration by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering.
4. That, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant's annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
5. Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Durham, North Carolina, on the 11th day of July, 2017.
| HEAT BIOLOGICS, INC. | |
|
|
|
| By: | /s/ Jeffrey Wolf |
| Name: | Jeffrey Wolf |
| Title: | President and Chief Executive Officer |
|
| (Principal Executive Officer) |
|
|
|
POWER OF ATTORNEY AND SIGNATURES
Each of the undersigned, whose signature appears below, hereby constitutes and appoints Jeffrey Wolf as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendments to this Registration Statement, whether pre-effective or post-effective, and to file the same with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, or his substitute, full power and authority to do and perform each and every act and thing necessary or appropriate to be done with respect to this Registration Statement or any amendments hereto in the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
EXHIBIT INDEX
Exhibit No. |
| Description of Document |
|
|
|
3.1 |
| Third Amended and Restated Certificate of Incorporation (1) |
3.2 |
| Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation (2) |
3.2 |
| Amended and Restated Bylaws (3) |
| Heat Biologics, Inc. 2017 Stock Incentive Plan (4) | |
| Opinion of Gracin & Marlow, LLP regarding Legality of Shares (4) | |
| Consent of BDO USA, LLP, Independent Registered Public Accounting Firm (4) | |
| Consent of Gracin & Marlow, LLP (contained in Exhibit 5.1) (4) | |
| Consent of BDO USA, LLP, Independent Auditor (4) | |
| Power of Attorney (included as part of the signature page to this Registration Statement and incorporated herein by reference) (4) |
————————
(1)
Incorporated by reference to the Registrant’s Form S-1 filed with the Securities and Exchange Commission on May 6, 2013.
(2)
Incorporated by reference to the Registrant’s Form S-1 filed with the Securities and Exchange Commission on May 30, 2013.
(3)
Incorporated by reference to the Registrant’s Form 8-K filed with the Securities and Exchange Commission on January 15, 2016.
(4)
Filed herewith.